The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension. (June 2020)

• Record Type: Journal Article
• Authors: Palma, Jose-Alberto; Redel-Traub, Gabriel; Porciuncula, Angelo; Samaniego-Toro, Daniela; Millar Vernetti, Patricio; Lui, Yvonne W.; Norcliffe-Kaufmann, Lucy; Kaufmann, Horacio
• Is Part Of: Parkinsonism & related disorders. Volume 75(2020)
• Page Start: 97
• Page End: 104
• Publication Date: 2020-06
• Subjects: Autonomic failure -- Hypertension -- Orthostatic hypotension -- Mortality -- Organ damage -- Survival; Parkinson's disease -- Periodicals; Movement disorders -- Periodicals; Movement Disorders -- Periodicals; Nerve Degeneration -- Periodicals; Nervous System Diseases -- Periodicals; Parkinson Disease -- Periodicals; Tremor -- Periodicals; Parkinson, Maladie de -- Périodiques; Parkinson's disease; 616.833
• DOI: 10.1016/j.parkreldis.2020.04.011
• Languages: English
• ISSNs: 1353-8020

Abstract

Abstract: Introduction: In addition to neurogenic orthostatic hypotension (nOH), patients with synucleinopathies frequently have hypertension when supine. The long-term consequences of both abnormalities are difficult to disentangle. We aimed to determine if supine hypertension is associated with target organ damage and worse survival in patients with nOH. Methods: Patients with nOH due to multiple system atrophy (MSA), Parkinson disease (PD), or pure autonomic failure (PAF) were classified into those with or without supine hypertension (systolic BP of at least 140 mmHg or diastolic BP of at least 90 mmHg). Organ damage was assessed by measuring cerebral white matter hyperintensities (WMH), left ventricular hypertrophy (LVH), and renal function. We prospectively followed patients for 30 months (range: 12–66 months) and recorded incident cardiovascular events and all-cause mortality. Results: Fifty-seven patients (35 with probable MSA, 14 with PD and 8 with PAF) completed all evaluations. In addition to nOH (average fall 35 ± 21/17 ± 14 mmHg, systolic/diastolic, mean ± SD), 38 patients (67%) had supine hypertension (systolic BP > 140 mmHg). Compared to those without hypertension, patients with hypertension had higher blood urea nitrogen levels (P = 0.005), lower estimated glomerular filtration rate (P = 0.008), higher prevalence of LVH (P = 0.040), and higher WMH volume (P = 0.019). Longitudinal follow-up of patients for over 2 years (27.1 ± 14.5 months) showed that supine hypertension was independently associated with earlier incidence of cardiovascular events and death (HR = 0.25; P = 0.039). Conclusions: Supine hypertension in patients with nOH was associated with an increased risk for target organ damage, cardiovascular events, and premature death. Defining management strategies and safe blood pressure ranges in patients with nOH remains an important research question. Highlights: Neurogenic orthostatic hypotension (nOH) and supine hypertension frequently coexist in patients with synucleinopathies. While essential hypertension has well defined deleterious consequences, it is unknow if these apply to supine hypertension. We found that supine hypertension in patients with synucleinopathies and nOH was associated with target organ damage. Supine hypertension was also associated with increased risk of cardiovascular events and shorter survival. Our findings have therapeutic implications for the treatment of patients with nOH.